Executive Health Insights
Translating medical leadership into strategy , governance and boardroom impact.
Critical Appraisal: 'Keep Britain Working – Final Report (Autumn 2025)'
The Keep Britain Working (KBW) review presents a comprehensive, data-driven response to the UK’s escalating economic inactivity crisis. It highlights how long-term illness, disability, and poor workplace health management have created a systemic drain on productivity — costing an estimated £212 billion annually (7% of GDP).
The Next Frontier of Corporate Governance: Integrating Health Intelligence into Board Risk and Strategy
Workforce health has become a critical governance issue. Over 800,000 UK workers have left employment due to long-term illness since 2019, costing the UK economy an estimated 7% of GDP annually (£132 billion). New EU regulations (CSRD) now mandate workforce health disclosure. Boards that integrate health intelligence into their risk frameworks can predict workforce disruption, prevent costly absences, and gain competitive advantage.
How Medical Leadership Transforms Board Strategy and ESG Performance
Explores how boards can translate medical leadership into governance, resilience, and financial advantage — and why fractional CMOs are redefining corporate health strategy.
Guidance Notes for Managers to Support Colleagues with ADHD
ADHD (attention deficit hyperactivity disorder) is a common neurodevelopmental condition that can be diagnosed in adults. Symptoms and their impact can range from mild to severe. Whatever level of ADHD an employee has, there is a legal and moral duty of care to support them appropriately. In this guide, we'll explore what ADHD is, common symptoms, and evidence-based strategies to support employees with ADHD in the workplace.